Demographic and Clinical Findings in Pediatric Patients Affected By inherited metabolic disease in Isfahan province

Slides:



Advertisements
Similar presentations
Alterations in Metabolic Status Jan Bazner-Chandler RN, MSN, CNS, CPNP.
Advertisements

Phenylketonuria (PKU)
Approach to Inborn Error of Metabolism in a Neonate Filomena Hazel R. Villa, MD PL2.
Genetic Diseases.
AMCHP 2005 Conference Newborn Screening in Maryland The Maryland Program Informed Consent Informational Materials Linkage to Services Challenges of Working.
A Clinical Approach to Inherited Metabolic
Genetic testing Biochemical genetic testing Cytogenetic testing Direct genetic testing Diagnostic testing Predictive testing Carrier testing Prenatal testing.
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Phenylketonuria (PKU)
Breast Cancer Research in the Developing World Dr. Steven Narod Canada Research Chair in Breast Cancer Boston – November 2009.
Biotinidase deficiency: clinical presentation, treatment and screening
Postnatal Screening – Diagnostic testing for metabolic disorders.
Inborn Errors Of Metabolism (IEM).
CARBOHYDRATE METABOLISM- INHERITED DISORDERS DR. Tagreed Osman.
Metabolic diseases of the liver Central role in metabolism Causes and mechanisms of dysfunction Clinical patterns of metabolic disease Clinical approach.
MAPLE SYRUP URINE DISEASE (MSUD) IS A METABOLISM DISORDER PASSED DOWN THROUGH FAMILIES IN WHICH THE BODY CANNOT BREAK DOWN CERTAIN PARTS OF PROTEINS. URINE.
Amino acid Profiling Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is amino acid profiling? Amino acids are.
Adults with Inborn Errors of Metabolism Farrah Rajabi, MD Clinical Genetics Fellow Boston Children’s Hospital New England Genetics Collaborative Annual.
Clinical Data to Support Qualification: Cross-Sectional Surveys and Natural History Studies P. K. Tandon, Ph.D. Clinical Science Officer Genzyme, a Sanofi.
Maple Syrup Urine Disease
PKU Phenylketonuria. What is PKU? PKU (phenylketonuria), is a rare, inherited metabolic disease that affects the way the body processes protein. People.
Inborn Errors of Metabolism Monica Egan. Video Links Part 1: – xWwY&feature=plcphttp://
Galactose γάλακτος galactose glucose In the human body, glucose is changed into galactose via hexoneogenesis to enable the mammary glands to secrete lactose.
Phenylketonuria (PKU) By: Greg Ancmon and Brennan Ramos Period 2.
Dr Shahida Mushtaq.  provides advanced understanding and applied knowledge in the theory and practice of Clinical Biochemistry  a critical understanding.
PKU- Cell Storage Disorder!! By: Brianna Hopkins.
Presenters: PICU/AO1 UNIT Moderators: Dr Somwe Dr Mwenechanya
HEREDITARY METABOLIC DISEASES. Particular risk factors are: Advanced maternal age (e.g. Down's syndrome) Family history of inherited diseases (e.g. fragile.
Phenylketoriuria (PKU)
What Do You Know About PKU?
Metabolic Disorders Inborn Errors of Metabolism Dr. Sara Mitchell.
Dr. Samah Kotb Nasr Eldeen Lecturer of Biochemistry Cellular Biochemistry and Metabolism (CLS 333 ) Inborn Errors of Metabolism (IEM)
Analysis of Genetic Disease Testing The Importance of Newborn Screening Ranimol N. Fromer Public Health Policy Analyst Michigan Department Health Department.
Maple Syrup Urine Disease (MSUD)
Nutritional therapy in children with in-born errors of metabolism.
Many hundred disorders resulting from this type of inheritance are known An affected individual is homozygous for the abnormal gene, having inherited an.
In the name of GOD carnitine transporter deficiency
Inborn Errors of Metabolism(IEM) Lecture 1 SDK December SDK December
Genetic Diseases. Analytical methods for the identification of genetic disease play an important part in the pediatric clinical chemistry laboratory.
1.Is NS-NPD caused by defect in a single gene or is more than one gene involved? Mutations in the NPC1, NPC2, and SMPD1 genes cause Niemann-Pick disease.
INBORN ERRORS OF METABOLISM (IEM)
Objectives: · Metabolism of fructose · Metabolism of galactose · Pathway of alcohol metabolism · Explain the metabolic defects (fructosuria , hereditary.
Tay-Sachs Disease n What is it? n A degenerative neurological disorder where virtual absence of activity of a lysosomal enzyme, hexosaminidase A n Biochemistry.
GENETIC BASIS OF DISEASE- part 2. Genetic basis of disease part 2 objectives a. Define inborn errors of metabolism b. Describe the common characteristic.
Autosomal recessive inheritance
Hemorrhagic disease of the newborn
KA 4: Ante- and postnatal screening
Prevention Diabetes.
Patient care in Brazil: opportunities and challenges
Nutrition and cognitive development
PREDICTORS IN DEVELOPMENT OF LEARING DISABILITIES INTRODUCTION-PURPOSE
Nutrition Management of Maple Syrup Urine Disease
Assessment of Growth & Development of Children
Enhanced Genetics Services Project (EGSP)
Protein Requirements in Inherited Metabolic Diseases
An Approach to Inborn Errors of Metabolism
Chapter 19 Inborn Errors of Metabolism
Influenza Vaccine Effectiveness Against Pediatric Deaths:
Inborn Error of Metabolism
Avail 20% Discount on Packages for Inherited Metabolic Disorders (IMDs) Aga Khan University Hospital Clinical Laboratories Packages.
HEREDITARY METABOLIC DISEASES
Amino Acid Biosynthesis & Degradation
Rhematoid Rthritis Respiratory disorders
Prevention Diabetes Dr Abir Youssef 29/11/2018.
Cri du Chat Ilana Horton.
به نام خدا.
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Phenylketonuria (PKU) is a rare genetic condition in which a baby cannot “metabolize,” or digest, an essential amino acid called phenylalanine that is.
Maple Syrup Urine By: Joe Harvey.
Presentation transcript:

Demographic and Clinical Findings in Pediatric Patients Affected By inherited metabolic disease in Isfahan province

M. Hashemipour Isfahan University of Medical Sciences R.Najafi Ilam University of Medical Sciences

 Metabolic disorders, which are ascribable to enzyme deficiency lead to either excessive or lack of special metabolic components  Mostly present themselves during infancy or neonatal ages or even adulthood  They lead to accumulation of abnormal biochemical substrates, which may have potential toxic roles

 Metabolic disorders have a wide range of clinical symptoms  Twenty percent of full-term infants who are suspected of infectious diseases may be affected by metabolic diseases  Different organs may be involved in metabolic disorders and simultaneously show pathological dysfunctions  Onset of disease may vary due to environmental factors and nature of the disease

 Categorized as autosomal recessive  History of infants’ sudden death,parental consanguinity can be exploited as a clinical clue for metabolic disorders.  Damages in vital organs, especially in brain, unless early proper treatment is performed  Screening methods help early diagnosis

Sign& symptom  During infancy, lethargy, poor feeding and vomiting may be developed due to these disorders  More importantly regression and mental retardation can affect unless early diagnosis and appropriate treatment are established

Paraclinical findings Metabolic acidosis, hyperammonemia, ketosis, sepsis-like conditions, bone marrow suppression,hypoglycemia, hepatic failure can also help the diagnosis process

Diagnosis  Measurement of plasma amino acids as well as the analysis of enzymes and organic acids existing in urine  Metabolic screening is not implemented in most of Middle East countries  Some of the studies demonstrated that these diseases are more prevalent in this region  This study aimed to evaluate some of the demographical and clinical findings in pediatric patients affected by IEM in Isfahan province

Material and Methods  This cross-sectional study was conducted on metabolic disorder patients within the seven years period of in Isfahan province  Covered a wide range of cases from new born infants to seventeen years old children  Evaluated demographic information as well as disease history, educational, general, developmental and clinical status of the patients

Material and Methods  Information was gathered through telephonic and face to face interviews  Inclusion criteria were clinical and paraclinical signs of IEM  Enzymatic and metabolic evaluation was conducted on patients’ blood in the Wagner Stibbe laboratory in Hanover, Germany.

Results  5100 patients were screened  392 patients were affected by one of the metabolic disorders  Girl 45.2%  Boy 54.8%  167/392 patients were diagnosed with organic acidemia

Type of diseasenumberpercentIncidence rate Methylmalonic/propionic acidemia 58151:10379 Free fatty acid oxidation disorder 3181:19419 Urea cycle disorder3181:19419 Tyrosinemia287.31:21500 Holocarboxylase/biotinidase246.21:25083 Galactosemia2361:26173 Maple syrupe urine disorder184.71:33444 Isovaleric acidemia184.71:33444 Glutaric aciduria194.81:31684 Mucopolysaccharidosis164.11:37625 Glycogen storage disorder153.91:40133 Frequency of different types of Inherited metabolic diseases

Type of diseasenumberpercentIncidence rate Lipid storage disorder123.11:50166 Homocystinuria92.11:66888 Gauchers disease71.81:86000 Mitochondrial disorder51.31: Fructose intolerance51.31: Cystinosis51.31: Peroxisomal disorder3.81: Lisinuric protein intolerance 1.31: Frequency of different types of Inherited metabolic diseases(continued)

incidence rate of metabolic disease 1: : live birth

Frequency of different subtypes of organic acidemia PercentNumberSubtypes of organic acidemia Methylmalonic/propionic acidemia Other organic acidemia 6.124Holocarboxylase/biotinidase 4.819Glutaric aciduria 4.618Isovaleric acidemia Total

Frequency of parental consanguinity in patients with IEM  Consanguineous marriage ;82.6% Third degree marriage ;63.5% Marriage in other familiar categories ;19.1%

 Mucopolysaccharidosis 86.7%  Gauchers disease 85.5%  Tyrosinemia 78.6%  Methylmalonic /propionic 60 % Frequency of parental consanguinity in different types of IEM

Type of diseaseGirls (%)Boys(%) Lipid storage disorder Homocystinuria50 Gauchers disease Mitochondrial disorder6040 Fructose intolerance8020 Cystinosis50 Peroxisomal disorder0100 Lisinuric protein intolerance1000 Methylmalonic/propionic acidemia Free fatty acid oxidation disorder Sex distribution in patients with different types off IEM

Type of diseaseGirls(%)Boys (%) Urea cycle disorder Tyrosinemia Holocarboxylase/biotinidase Galactosemia Maple syrupe urine disorder Isovaleric acidemia50 Glutaric aciduria Mucopolysaccharidosis Glycogen storage disorder6040 Sex distribution in patients with different types of IEM

Number of Hospitalization(days) in patients with IEM

The median age of disease onset in patients with IEM

Frequency of IEM diagnosis in different age group of patients

Frequency of different biochemical findings in patients with IEM  Acidosis %42  Hyperammonemia 21%  Hypoglycemia 11.1%

Frequency of different signs and symptoms in patients withIEM  Developmental delay 37.8%  Seizure 28.2%  Hepatomegaly 13%

Mortality rate in family with IEM Methylmalonic/propionic acidemia Free fatty acid oxidation disorder Glycogen storage disease The rate of mortality was higher in families of patients with metabolic disorders 38%

Frequency of death in IEM with higher rate of mortality Mitochonderial disorder 80% Maple syrupe urine disorder 44.4% Tyrosinemia 42.8%

The trend of IEM diagnosis from1386 to1393

Educational status of patients with IMD

Discussion

Trend of IEM diagnosis  During the study time,from 1386 to 1393,diagnosis of IEM had increasing trend, it may be due to;  Availability of sensitive diagnostic techniques  Increased knowledge of families about IMD  Increased clinical suspicion of physicians

Prevalence of IEM Reported incidence rate of IEM have great variability in different populations  England 40/  Saudi Arabia 150/  Australia 1/ 2855  Isfahan 1/1536

Prevalence of different types of IEM Reported prevalence rate of different types of IMD are not similar in different studies worldwide  In the study of Christiano et al. in Brazil, the most common types of IEM were PKU and MPS  In another study in Brazil lysosomal storage disease (59.8%) and aminoacidopathy (21.2%) were the most common types of IEM  In a study in India,the most frequent IEM was PKU with a prevalence rate of 27/ live birth

Prevalence of different types of IEM  In a study in Saudi Arabia, Moammar et al. have reported lysosomal storage disease as the most common IEM  Aminoacidopathy was reported as the most prevalent type of IEM in Bahrein,Lybia and Australia *During this study we did not include PKU cases

Prevalence of organic acidemia  Previous studies indicated that organic acidemia is more prevalent in the Middle East countries  1/8000 in Bahrain  150/ in Saudi Arabia Reported prevalence rate was lower in  Canada  Australia  Italy(1/21422 in Italy

Incidence rate of organic academia  In current study, incidence rate of organic acidemia was 27/100,000 live birth (1:3604)  PA/MAA with incidence rate of 1/10379 live births was the most common type of organic acidemia  (29% of organic acidemia cases)  Our findings regarding the higher prevalence rate of PA/MMA was in accordance with analogous studies conducted in China and Saudi Arabia, Pakistan and Egypt

Parental consanguinity and IMD  Parental consanguinity is considered as a risk factor for IEM  According to the report of WHO, prevalence of parental consanguinity is higher in Middle East countries,including Iran  Prevalence of consanguineous marriage was reported to be 30-40% in Iran  In this study, the rate of parental consanguinity was 82.6%in patients with IEM.

Parental consanguinity and IEM  In a study in Turkey, Stike et al. have indicated that consanguinity is one the main risk factors for higher rate of IEM  In another study in Saudi Arabia, Dammam and colleagues, have reported that parents of 57.7% of patients with IEM had consanguineous marriage.

Parental consanguinity and IEM  Karimzadeh et al. have reported parental consanguinity among 50% of patients with MMA  Rate of parental consanguinity was 84% (21/25) in the study of Golbahar  The rate was 86.9% in a study in Libya  In a study in Saudi Arabia by Hissa et al.,prevalence of parental consanguinity was 40-60% in different regions of the country.

Parental consanguinity and IEM  In the study of Chirstiano et al. in Brazil, prevalence of parental consanguinity was 25%  Al Ageel and colleagues have reported that the rate of parental consanguinity ranged between 60-70% in Middle east which result in occurrence of higher rate of specific genetic disorders in these regions.  Whereas prevalence of mentioned disorders are low or rare in Western countries with lower rate of parental consanguinity

Parental consanguinity and IEM  Genotypes of these diseases generally are autosomal recessive  Hamad waleed et al. found that consanguinity marriages rate were as high as 60 % in some societies which provided a risk factors of these metabolic diseases  Our study showed a higher frequency of parental consanguinity in PA/MAA patients

Signs and symptoms of IEM  It is suggested that signs and symptoms of the IMD is different in different studies regarding the methods of study and the type of IMD which is more common in the studied regions  In this study the most common clinical presentations of IMD were developmental delay and seizure  The most prevalent biochemical characteristics of the patients with IEM in our study were acidosis and hyperamonemia  In this study, most of the patients with PA/MMA presented by acidosis and more than 50% of them presented by developmental delay,seizure and hyperamonemia

Signs and symptoms of IEM  In a study in Pakistan,Shehla et al have reported that the two most common presentation of IEM in their studied patients were seizure and coma  In a study in Libya, hepatomegaly and jaundice were the more prevalent clinical presentations of IEM  Karimzadeh et al. have reported that the rate of developmental delay, seizure and acidosis among their studied patients with IEM, were 85%,60% and 25%,respectively

Signs and symptoms of IEM  Acidosis was found in half of the cases  One third of these patients had some degrees of developmental disorders and convulsion  One third of patients with IEM in the study of Kimberly in Canada and in a study in China had developmental delay  In another study, which was conducted by Wajner et al, organic acidemia cases dominantly showed neurologic abnormalities as well as metabolic acidosis, and growth retardation, in 65 %, 42 %, and 14 % of the cases respectively

Age of onset in IEM  In this study, more than 50% of clinical presentations of IEM were initiated during neonatal period, whereas 1/6 of the cases of IEM diagnosed during this period.  In the study of Shehla et al. in Pakistan,60% of patients with IEM diagnosed during neonatal period.  In the study which conducted in Libya, in 50% of cases, the presentations of IEM were initiated during 1-6 months after birth

Rate of mortality in IEM  In a study in Libya, the rate of mortality was 50%  In our study, the rate of mortality was 25%

Rate of mortality in IEM  Our study, as well as the previous one conducted by Wajner et al, documented a low frequency of mortality rate (25%).  On the contrary, mortality rates in France, Thailand and China were higher (29 %, 36 %, and 50 % respectively

Limitations  Lack of patient availability and cooperation, especially when they could not afford to pay for the paraclinical examinations, were assumed as our limitation

Conclusion  Although IEM is considered a rare disease, but totally it seems to be a common problem in our population  Early diagnosis and treatment would reduce the rate of mortality  Delay in diagnosis and treament would result in permanent development and motor impairment  Most of the patients with IEM need rehabilation  Most of the patients with IEM frequently require hospitalization

Conclusion  Almost all of the patients with IEM need special formula and diet as well as special care  The disorders has a high cost for both families and community  It is necessary to determine genetic mutations of the patients specially in populations with higher rate of parental consanguinity  Insurance should have better coverage for these patients

Conclusion  In general, early diagnosis of organic acidemia is obviously essential and can potentially prevent irremediable disorders.  Neonatal screening is crucial since the disease’s outcomes are improved when the age of the disease diagnosis is closer to onset of the disease.